COMMUNIQUÉS West-GlobeNewswire
![GlobalNewswire](/sites/santelog.com/www.santelog.com/themes/santelog/images/nasdacinner.png)
-
Avricore Grants Options
31/08/2024 - 03:29 -
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
31/08/2024 - 05:56 -
George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024
31/08/2024 - 09:54 -
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
30/08/2024 - 01:32 -
Raw Garden Announces End of Summer and Labor Day Deals
30/08/2024 - 02:50 -
HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China
30/08/2024 - 06:30 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
30/08/2024 - 10:39 -
BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board
30/08/2024 - 10:43 -
Trading by management and close relations of management
30/08/2024 - 12:17 -
Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC
30/08/2024 - 13:00 -
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
30/08/2024 - 13:00 -
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
30/08/2024 - 13:00 -
Opthea Reports Full-Year Financial Results and Business Updates
30/08/2024 - 13:30 -
Avicanna Announces Repayment of Debentures
30/08/2024 - 13:30 -
LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR Exon 19 Deletions or Exon 21 L858R Mutations
30/08/2024 - 13:30 -
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
30/08/2024 - 14:00 -
HOOKIPA Pharma Announces Board of Directors Changes
30/08/2024 - 14:00 -
Ventyx Biosciences Announces Departure of Chief Financial Officer
30/08/2024 - 14:00 -
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
30/08/2024 - 14:00
Pages